Duke-Margolis Comment Letter - Stop Drug Shortages Act

The Honorable Cathy McMorris Rodgers
Chair
Committee on Energy and Commerce
United States House of Representatives

August 25, 2023

Dear Chair McMorris Rodgers,

The Robert J. Margolis, MD, Center for Health Policy at Duke University (“Duke-Margolis” or “the Center”) appreciates this opportunity to provide comments and recommendations regarding the discussion draft of the Stop Drug Shortages Act. Our comments herein follow on our response to the July 2023 Request for Information issued by the Chair on the same topic, and we again thank the Chair, the Committee, and Committee staff for their focus on preventing drug shortages.

Duke-Margolis has conducted years of research and stakeholder engagement aimed at promoting drug supply chain resilience and preventing drug shortages, most recently including the launch of the new Duke-Margolis Drug Supply Chain Resilience and Advanced Manufacturing Consortium. The recommendations herein do not necessarily represent the views of any Consortium Members and are not intended to limit the ability of Consortium members to provide their own comments on behalf of their independent organizations, but are informed by the Center’s work with Consortium Members. In the coming weeks, Duke-Margolis will publish a white paper, also informed by our work with Consortium Members, with a broader set of recommendations for administrative and legislative action on drug shortages.

Click here to read the entire letter include the full list of Duke-Margolis recommendations.